MDR CE Marking Process: Steps, Timeline and Responsibilities
The MDR CE marking process takes a medical device from scoping and technical documentation to a notified body certificate under Regulation (EU) 2017/745. Once the notified body agreement is signed, it most often takes 13 to 18 months. This page sets out the 8 steps, a month-by-month timeline and who does what between I3CGLOBAL’s CE marking consultants and the manufacturer.
What Is the MDR CE Marking Process?
The MDR CE marking process is the project a manufacturer runs to place a medical device on the EU market under the Medical Device Regulation. It covers building the technical documentation, generating test and clinical evidence, submitting to a notified body, answering its questions, passing the quality system audit and receiving the certificate. After that, the manufacturer signs the EU declaration of conformity and affixes the CE marking.
This page looks at the process as a project: the order of the work, how long each stage takes and who delivers each part of the technical file. For the regulatory side, including conformity routes by device class and what a notified body checks, see our MDR CE marking approval flowchart. For full project support, see our medical device CE marking service.
MDR CE marking process at a glance
- Legal basis
- Regulation (EU) 2017/745 (MDR)
- Main deliverable
- Technical documentation under Annexes II and III
- Typical preparation
- About 4 months in our plan; manufacturers commonly report 6 to 12 months
- Notified body phase
- 13 to 18 months is the most commonly reported period (Commission survey, data to February 2026)
- Review rounds
- Plan for two rounds of notified body questions
- Final audit
- On-site quality management system audit by the notified body
- Our benchmark
- 18 months from the start of documentation to certificate
What Are the 8 Steps of the MDR CE Marking Process?
The MDR CE marking process runs in 8 steps: scoping, technical file build, evidence, notified body application, two review rounds, the quality system audit and the certificate. The first three steps sit mostly with the manufacturer and its consultant. The last five depend on the notified body’s schedule as well.
Scope and gap analysis
Fix the intended purpose, the device classification, the conformity route and the models in scope. A technical file gap analysis shows what already exists and what is missing.
Build the technical file
Compile the technical documentation in the Annex II structure: device description, labels and IFU, design and manufacturing, GSPR, risk and post-market documents.
Complete the evidence
Close testing gaps such as biocompatibility, electrical safety, sterilisation and shelf life, and finish the clinical evaluation report so every claim is supported.
Apply to a notified body
Choose a notified body designated for your device codes, lodge the application and sign the agreement. This often takes one to three months on its own.
First review round
The notified body reviews the technical documentation and sends its first list of questions and non-conformities. You answer each one with evidence.
Second review round
The notified body checks your answers and raises any remaining points. A well-prepared file closes here without a third round.
Quality system audit
The notified body audits your quality management system on site, usually against ISO 13485 and the MDR, and checks that design, production and post-market processes work.
Certificate and CE marking
The notified body issues the certificate. You sign the EU declaration of conformity, affix the CE marking, register in EUDAMED and keep the file up to date.
How Long Does the MDR CE Marking Process Take?
The MDR CE marking process typically takes about 18 months from the start of documentation to the certificate in I3CGLOBAL projects. That is roughly 4 months of preparation and 14 months with the notified body. The European Commission’s 20th notified bodies survey, with data to 28 February 2026, reports 13 to 18 months as the most common period from signed agreement to certificate.
Timelines drive budgets, launch plans and investor conversations, so it helps to see where the months go. The chart below shows our experience-based plan for a typical class IIa or IIb device. Your plan will move with the device, the state of your evidence and notified body capacity.
| Stage | Months in our plan | What happens |
|---|---|---|
| Preparation | M1 to M4 | Gap analysis, technical file compilation, test plans and clinical evaluation |
| First review | M5 to M11 | Notified body review of the technical documentation, then your answers to its questions |
| Second review | M12 to M15 | Check of your answers and closure of the remaining points |
| QMS audit | M16 to M17 | On-site audit of the quality management system and closure of any findings |
| Certificate | M18 | Certificate issued, declaration of conformity signed, CE marking affixed |
Before month 1: lodging the application and signing the notified body agreement often takes one to three months. Start this in parallel with preparation so it does not add to the 18 months. Compare notified body fees and our CE certification cost guide when you budget.
Class I devices that are not sterile, do not measure and are not reusable surgical instruments skip the notified body stages. For them, the MDR CE marking process ends when the technical documentation is complete and the declaration of conformity is signed, so the timeline depends on your own preparation.
What Delays the MDR CE Marking Process, and How Can You Shorten It?
Most delays in the MDR CE marking process come from the manufacturer’s side, not the notified body. Commission surveys have repeatedly found that around 60% of the review time sits with the manufacturer, mostly in preparing answers. That is the part you can control.
Common causes of delay
- An incomplete application that the notified body cannot accept
- Clinical evidence that does not support every claim, or a weak equivalence case
- Gaps between the GSPR checklist and the test reports
- Different intended purpose, indications or warnings in the IFU, risk file and clinical evaluation
- Test reports to old standard versions, or missing tests such as biocompatibility or usability
- Slow or partial answers to notified body questions
How to shorten the timeline
- Run a gap analysis before you apply, not after the first review
- Start long tests such as shelf life and biocompatibility early
- Lodge the notified body application while the file is being finished
- Keep one intended purpose across every document, with version control
- Answer each question with evidence and a document reference, within the agreed time
- Get your QMS audit-ready while the technical review is running
Who Does What in the MDR CE Marking Process?
In the MDR CE marking process, the manufacturer supplies the device data and stays legally responsible for the technical documentation. I3CGLOBAL scopes, drafts, reviews and compiles it, and liaises with the notified body. The matrix below splits every section of MDR Annex II between the two, in the order a technical file is built.
Several rows change with the device type. Sterile, implantable, active and software-driven devices need different standards and tests, so the matrix notes where expectations differ. For the file structure itself, see our MDR technical documentation table of contents and types of MDR technical files.
| Annex II Clause | Description | Scope of I3CGLOBAL | Scope of Client |
|---|---|---|---|
| Phase 1 – Device Introduction | |||
| 0 | INTRODUCTION |
| Review and confirm the scope of technical documentation. |
| 0 | TECHNICAL FILE DETAILS |
| Provide internal document control and record control numbers as per EN ISO 13485 procedures. |
| 0 | REVISION HISTORY | Prepare and maintain the TDF revision history template; log changes at every review cycle / update as applicable (Until granting CE) | Inform I3CGlobal of any device or changes requiring a new revision entry. |
| 0 | WARNING | Insert the standard confidentiality/proprietary information notice as per company practice. | Confirm the confidentiality classification of the technical file as per EN ISO 13485 / GMP procedure. |
| 0 | TECHNICAL FILE | Compile and format the complete technical documentation file (TDF) as per MDR Annex II (both Part A and Part B annexures / supporting evidence). | Provide all device-specific source documents and data required for compilation wherever applicable and as per your availability. |
| 0 | PURPOSE | Draft the purpose statement of the TDF with reference to MDR 2017/745. | Review and approve the purpose statement. |
| 0 | SCOPE | Define the scope of the technical file, covering the device models/variants under review. | Confirm the exact models, variants and accessories to be included in the scope. |
| 0 | COMPANY PROFILE | Review and update in TDF | Provide company profile details – history, facilities, and certifications held. |
| 0 | LEGAL NAMES AND ADDRESS OF THE MANUFACTURER |
|
|
| 0 | EUROPEAN UNION AUTHORIZED REPRESENTATIVE | Review EAR agreement, mandate and EAR SRN details along with PRRC. | Confirm the appointment of the EU Authorized Representative and provide the mandate, agreement and SRN |
| 0 | NOTIFIED BODY |
| Provide the notified body name, identification number and certificate details (if already engaged). |
| Phase 2 – Device Description and Specification, Including Variants and Accessories / Components / Modules | |||
| 1.1a | PRODUCT OR TRADE NAME | Format and insert the product/trade name in the document. | Provide the confirmed product/trade name(s). |
| 1.1a | GENERAL DESCRIPTION |
|
|
| 1.1a | INTENDED PURPOSE |
| Provide the intended purpose statement of the device. |
| 1.1a | INTENDED USERS |
| Identify the intended user group(s) (e.g., healthcare professional, layperson). |
| 1.1b | BASIC UDI-DI |
| Generate and provide the basic UDI-DI via the assigned issuing agency. |
| 1.1c | THE INTENDED PATIENT POPULATION |
| Provide the intended patient population details. |
| 1.1c | MEDICAL CONDITIONS |
| Provide the medical condition(s) the device is intended to treat, diagnose or monitor. |
| 1.1c | INDICATIONS |
| Provide the indications for use. |
| 1.1c | CONTRA-INDICATIONS | Draft the contraindications based on the labelling requirements from Risk and Clinical Evaluation |
|
| 1.1c | WARNINGS | Cross-check warnings against GSPR and labelling requirements from Risk and Clinical Evaluation | Provide the list of warnings/precautions associated with device use. |
| 1.1d | PRINCIPLE OF OPERATION | Draft/review the principle of operation description for regulatory clarity. | Provide the technical explanation of how the device works (mechanism of action). |
| 1.1e | MEDICAL DEVICE RATIONALE | Draft the rationale for qualifying the product as a medical device under MDR Article 2 or MDCG 2019-11 | Provide supporting technical/clinical rationale and intended medical purpose evidence. |
| 1.1f | DEVICE CLASSIFICATION AND JUSTIFICATION | Perform device classification per MDR Annex VIII and prepare the classification justification/rationale document per MDCG 2021-24, Rev.1; classify embedded firmware safety class per IEC 62304 where applicable. | Provide the details required for classification and review/approve the classification. |
| 1.1g | EXPLANATION OF NOVEL FEATURES | Draft the section highlighting novel design features, materials, or (where applicable) algorithms/AI-ML functions, versus previous/prior-generation versions | Identify and describe the novel design features, materials, or (where applicable) algorithms/AI-ML functions, versus previous/prior-generation versions |
| 1.1h | DESCRIPTION OF THE ACCESSORIES | Compile description of accessories (e.g., external programmer/controller, leads, cables, consumables) and their interaction with the device. | Provide description of all accessories supplied with or used alongside the device. |
| 1.1i | DESCRIPTION OF THE VARIANTS | Send a requisition to the client for modules, versions or configurations, if applicable covered in the scope of TDF and prepare the consolidated section as per MDR Annex II, Section 1. |
|
| 1.1j | COMPONENTS DESCRIPTION WITH DRAWINGS |
|
|
| 1.1k | DESCRIPTION OF THE RAW MATERIALS | Review the raw materials list / Bill of Materials (BOM), including patient-contacting materials. | Provide the raw materials list / Bill of Materials (BOM) with material certificates/traceability. |
| 1.1l | TECHNICAL SPECIFICATIONS | Compile and review the technical specification tables/section. | Provide detailed technical specifications (dimensions, weight, materials, performance parameters, power/battery, connectivity, ingress protection, etc. as applicable) |
| 1.2a | AN OVERVIEW OF THE PREVIOUS GENERATION | Review the previous versions provided | Provide previous released versions in the market |
| 1.2b | AN OVERVIEW OF EQUIVALENT OR SIMILAR DEVICES | Assist in identifying equivalent and similar devices and list them, with comparisons based on high-level technical specifications. | Provide technical and clinical information of the equivalent/similar device (if the equivalence route is pursued). |
| Phase 3 – Information to be Supplied by the Manufacturer | |||
| 2 | LABELS | Review label and symbol content against MDR labelling requirements (Annex I, 23.1–23.4) and ISO 15223-1 symbols; provide corrections. | Provide the content of all device labels and its deployment information |
| 2 | IFU | Review IFU content against MDR Annex I check requirements, risk, clinical and applicable standards and provide corrections. | Provide the draft Instructions for Use in all required languages. |
| Phase 4 – Design and Development Information | |||
| 3a | DESCRIPTION OF THE DESIGN | Compile and review the device design description/design controls summary, covering mechanical, electronic (where applicable) and firmware (where applicable) design, and the development plan. |
|
| 3b | MANUFACTURING PROCESSES | Review the manufacturing process flow and methodology shared | Provide the manufacturing process flow, methodology and process validation records (IQ/OQ/PQ) used for production |
| 3b | FINAL PRODUCT SPECIFICATION AND TESTING |
|
|
| 3b | MANUFACTURING ENVIRONMENTAL CONTROLS | Format the manufacturing environment/cleanroom controls section and cross-check against applicable standards. | Provide details of cleanroom classification (where applicable), environmental monitoring and contamination controls used in manufacturing |
| 3c | SUPPLIERS AND SUBCONTRACTORS | Review the BOM and list the suppliers and subcontractors |
|
| Phase 5 – General Safety and Performance Requirements (GSPR) | |||
| 4 | THE GENERAL SAFETY AND PERFORMANCE REQUIREMENTS | Complete the GSPR checklist, referencing supporting evidence/documents, and identify gaps. | Provide test reports, standards compliance data and technical justifications for each GSPR. |
| 4 | DECLARATION OF CONFORMITY | Prepare the Declaration of Conformity as per MDR Annex IV. | Review and sign the Declaration of Conformity. |
| 4c, 4d | LIST OF APPLICABLE LEGISLATION | Identify and compile the list of applicable EU legislation | Confirm any additional national/regional legislation applicable to the device. |
| 4c, 4d | LIST OF APPLICABLE GUIDELINES | Identify and compile applicable MDCG guidance documents. | Review and confirm the applicability of the listed guidelines. |
| 4c, 4d | LIST OF APPLICABLE HARMONIZED STANDARDS | Identify applicable harmonized standards (per the EU Official Journal) and compile the list. | Confirm standards tested against and provide certificates of compliance. |
| 4c, 4d | LIST OF APPLICABLE NON-HARMONIZED STANDARDS | Identify relevant non-harmonized / state-of-the-art standards applicable to the device. | Confirm any additional standards followed and provide supporting test reports. |
| Phase 6 – Benefit-Risk Analysis and Risk Management | |||
| 5a | THE BENEFIT-RISK ANALYSIS | Prepare/review the benefit-risk analysis and methodology as per Annex I, Chapter I. | Provide clinical/technical data supporting the benefit-risk determination. |
| 5b | RISK MANAGEMENT | Review the risk management file against ISO 14971 (and IEC 62304 / ISO/IEC 27001 / MDCG 2019-16 where firmware or connectivity is present); identify gaps and provide corrective guidance. | Conduct the risk management activities and provide the complete risk management file (plan, analysis, evaluation, control, and report). |
| Phase 7 – Verification and Validation | |||
| 6.1a | PRE-CLINICAL SAFETY | Review pre-clinical safety/bench data (and VAPT reports where the device is networked/wireless) for completeness against the GSPR. | Provide pre-clinical bench test reports and, where applicable, Vulnerability Assessment & Penetration Testing (VAPT) reports. |
| 6.1b | BIOCOMPATIBILITY OF THE DEVICE | Review the biocompatibility evaluation/testing against the ISO 10993 series for all patient-contacting materials and identify gaps. | Provide biocompatibility test reports/biological evaluation per ISO 10993-1 for all body-contacting materials. |
| 6.1b | ELECTRICAL SAFETY AND ELECTROMAGNETIC COMPATIBILITY | Review electrical safety and EMC test reports against the applicable IEC 60601 series (and ISO 14708 series where relevant) and identify gaps. | Provide electrical safety and EMC test reports per the applicable IEC 60601 series (and ISO 14708 particular standard where relevant). |
| 6.1b | SOFTWARE / FIRMWARE VERIFICATION AND VALIDATION | Review software/firmware V&V documentation against IEC 62304 and MDR requirements; provide gap analysis. | Provide software/firmware development lifecycle documentation, verification/validation test plan & reports and the software safety & security risk management file. |
| 6.1b, 6.2e | STERILIZATION | Review the sterilization validation (method, dose/cycle, SAL) against ISO 11135 / ISO 11137 / ISO 17665 as applicable and identify gaps. | Provide sterilization validation reports (method, SAL 10⁻⁶ demonstration) per the applicable ISO 11135/11137/17665 standard. |
| 6.1b | STABILITY | Review shelf-life/aging (and, where applicable, battery longevity) stability data and identify gaps. | Provide shelf-life (real-time and accelerated aging) test reports, and battery longevity/stability data where applicable. |
| 6.1c | CLINICAL EVALUATION | Prepare/review the Clinical Evaluation Report (CER) as per MEDDEV 2.7/1 Rev.4 and MDR and MDCG 2020-1 requirements. | Provide clinical data, literature search inputs and post-market clinical follow-up (PMCF) data as available. |
| 6.1d | POST-MARKET ACTIVITIES | Prepare/review the PMS plan, PMS report/PSUR and PMCF plan templates. | Provide post-market surveillance data, complaints, vigilance reports and PMCF data. |
| 6.1d,6.2e | PACKAGING AND TRANSPORTATION | Review packaging (sterile barrier where applicable) and transport/shipping validation against the applicable standards and identify gaps. | Provide packaging validation (ISO 11607-1/-2 where sterile) and transport/shipping simulation test reports. |
| 6.2a | MEDICINAL PRODUCTS WITHIN THE MEANING OF DIRECTIVE 2001/83/EC | Not Applicable, unless the device incorporates a medicinal substance (e.g., a drug-eluting component). | Not Applicable, unless the device incorporates a medicinal substance. |
| 6.2b | TISSUES OR CELLS OF ANIMAL ORIGIN | Not Applicable, unless the device incorporates animal-derived materials. | Not Applicable, unless animal-derived materials are used. |
| 6.2c | DEVICES THAT ARE COMPOSED OF SUBSTANCES OR COMBINATIONS OF SUBSTANCES | Not Applicable, unless the device is absorbed by or locally dispersed in the human body. | Not Applicable, unless applicable to the device design. |
| 6.2d | CMR OR ENDOCRINE-DISRUPTING ACTIVITY | Review device materials against MDR Annex I, Section 10.4 for CMR/endocrine-disrupting substances present above 0.1% w/w and prepare justification if present. | Provide a full material declaration and justification for any CMR/endocrine-disrupting substances present above 0.1% w/w. |
| 6.2e | STERILIZATION | Cross-reference the sterilization validation summary compiled under Section 6.1.5. | Confirm sterilization method and validation status. |
| 6.2f | MEASURING FUNCTION | Partially Applicable – where the device includes a measuring/sensing function, it is evaluated under device verification & validation. Review the accuracy/metrological verification data. | Provide accuracy/metrological verification data. |
| 6.2g | COMBINATION WITH OTHER DEVICES | Partially Applicable – interfaces with accessories/consumables or connected devices are evaluated under device verification & validation. Review the list of interfaces/accessories. | Provide details of the interfaces/accessories connected to or used with the device. |
| 0 | MANUFACTURER DECLARATION | Prepare the manufacturer declaration template for the specific-case section. | Review and sign the manufacturer declaration. |
| Phase 8 – Conclusion and Approval | |||
| 0 | CONCLUSION AND APPROVAL | Prepare the final review summary and compile the complete technical file for client approval. | Perform the final review and provide sign-off/approval of the technical documentation. |
The result is a technical file that is complete, internally consistent and structured the way assessors expect. If you want ready-made structures, see our MDR technical file templates.
What Should You Prepare Before Starting the MDR CE Marking Process?
Have these inputs ready before the MDR CE marking process starts. Each one is a source document that only the manufacturer can provide, and a missing item is the most common reason the preparation stage runs late.
- Device description, intended purpose, intended users and patient population
- Models, variants, accessories and the product or trade names
- Engineering drawings, bill of materials and material certificates
- Manufacturing process flow, process validation records and critical suppliers
- Labels and instructions for use, and a plan for MDR labelling in the required languages
- Test reports: electrical safety and EMC, biocompatibility, sterilisation validation, packaging, shelf life and software, where relevant
- Risk management file, usually following ISO 14971 (see medical device risk management)
- Clinical data and literature for the clinical evaluation, plus any PMCF data
- Quality management system records, usually under ISO 13485
- Your EU authorised representative mandate and PRRC details, if you are outside the EU
- Basic UDI-DI from your issuing agency (see UDI system)
Want a realistic plan for your device?
Our CE marking consultants review your product profile and map the MDR CE marking process phase by phase and month by month.
MDR CE Marking Process: Frequently Asked Questions
How long does the MDR CE marking process take?
In I3CGLOBAL projects, the MDR CE marking process takes about 18 months from the start of documentation to the certificate. The European Commission’s 20th notified bodies survey, with data to 28 February 2026, reports 13 to 18 months as the most common period from signed notified body agreement to certificate.
What is the difference between the CE certification process and CE marking?
The CE certification process is the notified body’s assessment, which ends with an MDR certificate. CE marking is the step that follows: the manufacturer signs the EU declaration of conformity and affixes the CE mark, with the notified body number where one was involved.
How many notified body review rounds should I expect?
Plan for two rounds of questions on the technical documentation. A complete, consistent file can close in two rounds. Gaps in clinical evidence or testing often lead to a third round, which adds months to the MDR CE marking process.
Does a class I device follow the same MDR CE marking process?
Not fully. A class I device that is not sterile, does not measure and is not a reusable surgical instrument needs no notified body. The manufacturer prepares the technical documentation, signs the declaration of conformity and registers in EUDAMED. Class Is, Im and Ir devices need a notified body for those aspects only.
What does the manufacturer need to provide?
The manufacturer provides the source data: device description and intended purpose, drawings and bill of materials, manufacturing information, test reports, the risk management file, clinical data, labels and instructions for use, and quality system records. The consultant drafts, reviews and compiles these into the technical file.
Who is responsible for the technical documentation?
The manufacturer is legally responsible for the technical documentation under the MDR, even when a consultant prepares it. In our projects, I3CGLOBAL drafts, reviews and compiles each Annex II section, and the manufacturer supplies the data, reviews and signs off.
Can the MDR CE marking process be done faster?
Yes, mainly on the manufacturer’s side. Run a gap analysis before applying, start long tests early, apply to the notified body in parallel with preparation and answer every question with evidence. Notified body queue time cannot be shortened, but a complete file avoids extra review rounds.
What happens after the CE certificate is issued?
The manufacturer signs the EU declaration of conformity, affixes the CE marking and completes EUDAMED registration. MDR certificates are valid for up to five years, with surveillance audits at least every 12 months, plus post-market surveillance, vigilance and change control.
Official References and Related Guides
- Regulation (EU) 2017/745 (MDR)
- European Commission: 20th notified bodies survey
- European Commission: MDCG guidance documents
- Your Europe: CE marking
- MDR CE Marking Approval Flowchart
- Medical Device CE Marking
- Medical Device Technical File
- MDR Technical File Gap Analysis
- Medical Device Classification
- EU MDR Clinical Evaluation
- GSPR
- Notified Bodies List
- EU Declaration of Conformity
- Post-Market Surveillance Plan
- EUDAMED Registration
- PMCF
Updated 19 November 2026 | Author: Sobha Augustine, Founder, I3CGLOBAL | Reviewed by: Asha Johnson, Manager, I3CGLOBAL
